Related Experiment Videos
Acute lymphoblastic leukemia with t(4;11) translocation after osteogenic sarcoma
J Kapelushnik1, I Dubé, P Wilson
1Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada.
Cancer
|June 1, 1991
Summary
This study details a rare case of acute lymphoblastic leukemia (ALL) with a specific genetic marker (t(4;11)) that developed after osteogenic sarcoma treatment. The findings suggest a potential link between prior cancer therapy and secondary leukemia development.
Area of Science:
- Hematology
- Oncology
- Genetics
Background:
- Osteosarcoma is a primary bone cancer. Acute lymphoblastic leukemia (ALL) is a cancer of the blood and bone marrow. The t(4;11) translocation is a specific chromosomal abnormality associated with certain types of ALL.
Observation:
- A patient developed acute lymphoblastic leukemia (ALL) with the t(4;11) chromosomal translocation nine months after receiving treatment for osteogenic sarcoma.
- Cell surface marker and molecular analyses indicated that the leukemia originated from early B lineage cells.
Findings:
- This case represents the first documented instance of t(4;11) ALL occurring subsequent to osteogenic sarcoma treatment.
- The specific genetic profile (t(4;11)) in the secondary ALL suggests a potential link to the earlier cancer and its treatment.
Implications:
- The findings support the hypothesis that exposure to carcinogens, potentially from osteosarcoma treatment, may increase the risk of developing secondary leukemias, particularly those with the t(4;11) abnormality.
- This case highlights the importance of monitoring patients with a history of cancer for secondary malignancies, especially leukemia.
- Further research is warranted to elucidate the precise mechanisms by which prior cancer therapies might contribute to the development of specific leukemia subtypes like t(4;11) ALL.